Immunome, Inc. (IMNM) earnings
IMNM earnings moved a median of -1.87% by the close. Quarterly and annual IMNM reports and results, each read against the price at its own news timestamp. Back to the IMNM overview →
21 measured IMNM earnings events.
Where these IMNM earnings landedvs 21 measured IMNM earnings reactions
| Middle 50% of IMNM earnings reactions | -5.09% to +2.36% |
|---|---|
| Median reaction (to close) | -1.87% |
| Measured reactions | 21 |
Point-in-time · zero look-ahead
Half of the 21 IMNM earnings events with a measured close landed between -5.09% and +2.36%; 29% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Immunome Inc. For: Jun 30 | SEC filing · Form 10-Q | +1.95% | +9.38% | |
| Immunome Reports Second Quarter 2026 Financial Results and Provides Business Update | Press release | +1.95% | +9.38% | |
| Form 10-Q Immunome Inc. For: Mar 31 | SEC filing · Form 10-Q | -2.59% | -5.09% | |
| Immunome Reports First Quarter 2026 Financial Results and Provides Business Update | Press release | -2.59% | -5.09% | |
| Form 10-K Immunome Inc. For: Dec 31 | SEC filing · Form 10-K | -1.41% | +2.36% | |
| Form 10-Q Immunome Inc. For: Sep 30 | SEC filing · Form 10-Q | -1.75% | -1.36% | |
| Immunome Reports Third Quarter 2025 Financial Results and Provides Business Update | Press release | -1.75% | -1.36% | |
| Form 10-Q Immunome Inc. For: Jun 30 | SEC filing · Form 10-Q | -1.21% | -7.84% | |
| Immunome Reports Second Quarter 2025 Financial Results and Provides Business Update | Press release | -1.21% | -7.84% | |
| Form 10-Q Immunome Inc. For: Mar 31 | SEC filing · Form 10-Q | -1.37% | -5.50% | |
| Immunome Reports First Quarter 2025 Financial Results and Provides Business Update | Press release | -1.37% | -5.50% | |
| Form 10-K Immunome Inc. For: Dec 31 | SEC filing · Form 10-K | +0.36% | +2.85% | |
| Form 10-Q Immunome Inc. For: Sep 30 | SEC filing · Form 10-Q | -1.43% | -3.72% | |
| Immunome Reports Third Quarter 2024 Financial Results and Provides Business Update | Press release | -1.43% | -3.72% | |
| Form 10-Q Immunome Inc. For: Jun 30 | SEC filing · Form 10-Q | -0.35% | +6.20% | |
| Immunome Reports Second Quarter 2024 Financial Results and Provides Business Update | Press release | -0.35% | +6.20% | |
| Form 10-Q Immunome Inc. For: Mar 31 | SEC filing · Form 10-Q | +3.07% | -1.87% | |
| Immunome Reports First Quarter 2024 Financial Results and Provides Business Update | Press release | +3.07% | -1.87% | |
| Form 10-K Immunome Inc. For: Dec 31 | SEC filing · Form 10-K | -4.31% | -10.88% | |
| Form 10-Q Immunome Inc. For: Sep 30 | SEC filing · Form 10-Q | +0.00% | -1.61% | |
| Immunome Reports Third Quarter 2023 Financial Results | Press release | +0.00% | -1.61% |
Keep exploring
More IMNM: analyst actions → · SEC filings → · IMNM overview →